<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04131361</url>
  </required_header>
  <id_info>
    <org_study_id>R.19.10.644</org_study_id>
    <nct_id>NCT04131361</nct_id>
  </id_info>
  <brief_title>Inferior Vena Cava Diameter Dependent Colloid Challenge Versus Routine Crystalloid Strategy Transurethral Resection Prostate</brief_title>
  <official_title>Ultrasound-guided Inferior Vena Cava Diameter Dependent Colloid Challenge Versus Routine Crystalloid Strategy Fluid Replacement in Transurethral Resection Prostate (TURP) Under Spinal Anesthesia; A Prospective Randomized Controlled Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mansoura University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mansoura University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Intravenous fluid replacement during transurethral resection of the prostate is
      still unclear. Ultrasonography of the inferior vena cava (IVC) has been recently used to
      assess the volume status and predict fluid responsiveness. In this double-blind, randomized
      controlled study, we will assess the IVC at baseline and at subsequent time points after
      spinal anesthesia, and according to IVC diameter will give the replacement challenge colloid.
      Potential problems during TURP are mostly due to either fluid overload or bleeding:
      Intraoperative TURP syndrome, Hemorrhage, Myocardial ischemia, Hypothermia, Prostatic
      capsular perforation, Bladder or urethral perforation. Postoperative TURP syndrome,
      myocardial ischemia/infarction, Postoperative cognitive impairment. Study Hypothesis: Strict
      colloid volume optimization using US-guided IVC diameter calculation aiming decrease the
      total IV fluid volume and accommodate the transurethral inevitable absorption of currently
      used irrigation crystalloid fluid (Nacl0.9%) that accidentally absorbed and change it from a
      circulatory overload to a complementary part of the replacement IV fluids preventing fluid
      overload and TURP syndrome. Aim of the work: To reduce Intraoperative and postoperative fluid
      overload during TURP surgery with hemodynamic stability relaying up on US-guided IVC diameter
      dependent Strict IV Colloid replacement volume optimization. Methods: A prospective
      randomized controlled trial on ASAI-III male patient aged 40-80 years old subjected to
      transurethral endoscopic resection of the prostate (TURP) surgery. Then patients will be
      divided into 2 groups according to the IV infusion fluid type as follow: Crystalloid -control
      group: (preload plus continuous IO Ringer acetate crystalloid 4/2/1 rule infusion) according
      to the usual 4/2/1 rule. Not guided by IVC diameter but IVC diameter will be calculated using
      the US and recorded at baseline just after spinal anesthesia and then every 30 minutes till
      the end of surgery. Loop Diuretic (Furosemide) will be given according to the maximum
      diameter of the IVC as follow; 10mg if IVC&gt;2.5Cm. Colloid- study group: (preload plus colloid
      challenge only); Fluid challenge boluses of 250 mL (over 5 minutes using a pressurizer) 6%
      hydroxyethyl starch 130/0.4 in 0.9% sodium chloride (voluven®) if the IVC&lt;1.7(higher limit of
      normal) will be given guided by IVC diameter at baseline just after spinal anesthesia and
      then every 30 minutes till the end of surgery.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative serum Na+ (at end of surgery).</measure>
    <time_frame>just after end of surgery</time_frame>
    <description>venous sample</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">34</enrollment>
  <condition>Volume Overload</condition>
  <arm_group>
    <arm_group_label>Crystalloid -control group:</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Colloid- study group:</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Ultrasound-guided Inferior vena cava diameter dependent colloid challenge versus routine crystalloid strategy Fluid replacement</intervention_name>
    <description>The inferior vena cava largest and smallest diameters will be measured proximal to the opening of the hepatic veins in the longitudinal axis with the M-mode using a 8-2 MHz curved array ultrasound probe placed longitudinally in the subcostal region.</description>
    <arm_group_label>Colloid- study group:</arm_group_label>
    <arm_group_label>Crystalloid -control group:</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion Criteria:

               -  Patients subjected to transurethral resection of prostate TURP.

               -  ASA I&amp;III.

               -  Age 40-80years old.

               -  Surgical procedure: laser and Bipolar TURP using saline 0,9% irrigation.

          -  Exclusion Criteria:

               -  Height &lt;150 cm.

               -  Weight &lt;60 kg.

               -  Body mass index ≥45 kg/m2.

               -  Contraindications to spinal anesthesia (increased intracranial pressure or local
                  skin infection).

               -  Uncontrolled; Diabetes mellitus, cardiovascular failure, cerebrovascular
                  uncontrolled deficite, or other renal disease.

               -  Hemoglobin &lt;10 gm/dL.

               -  International Normalized Ratio &gt;1.4

               -  Platelet count &lt;100,000 /mm3.

               -  Preoperative serum creatinine &gt;1.5 mg/dL
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>mohamed Ghanem</last_name>
    <phone>00201067883998</phone>
    <email>mohamed.abdel_latif@yahoo.com</email>
  </overall_contact>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>October 12, 2019</study_first_submitted>
  <study_first_submitted_qc>October 17, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 18, 2019</study_first_posted>
  <last_update_submitted>October 17, 2019</last_update_submitted>
  <last_update_submitted_qc>October 17, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mansoura University</investigator_affiliation>
    <investigator_full_name>Mohamed Abd Latif Ghanim</investigator_full_name>
    <investigator_title>Associate Professor os anesthesia ICU &amp; Pain medicine.</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

